Evotec SE Stock: Rating & Analysis 2026

0.0/ 10Low

StockScorer score

Evotec SE mainly meets criteria in the Growth category. Result from 18 strategies checked.

View all strategies →

18Strategies checked

Match per strategy (excerpt)

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

Mohanram G-Score: Growth QualityThe substance check for growth stocks: separates investment from hot air.
Medium
Earnings Quality: Accrual Check (Sloan)Are the profits real? The Sloan ratio exposes book profits without cash.
High
PEG Strategy (Peter Lynch)Growth at a reasonable price: the P/E ratio relative to earnings growth.
Medium

15 more strategies locked

Unlock for free →

Metrics & fundamentals

P/E, ROE, margin, debt, cash flow and more for Evotec SE, fully visible after signing up for free.

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

StockScorer score
EVT.DE	Evotec SEthis page
LLY	Eli Lilly and Company	High6.7
LLY.TO	Eli Lilly and Company	Medium2.5
JNJ	Johnson & Johnson	High6.7
ABBV	AbbVie Inc	locked
UNH	UnitedHealth Group Incorporated	locked

Unlock the full peer comparison →

Evotec SE stock at a glance

Evotec SE stock (EVT.DE) is evaluated entirely rule-based in the StockScorer model. It currently reaches a StockScorer score of 0.0 out of 10, which corresponds to a low match with the underlying strategies. The classification is deliberately neutral and is not a recommendation to buy, hold or sell.

The rating focuses on growth metrics such as revenue, earnings and margin development. Overall, the stock passes through 18 different strategies, from momentum through quality to asset and dividend approaches.

Sector classification: Healthcare

Evotec SE is assigned to the Healthcare sector. The sector classification makes it possible to compare the stock with peers from the same sector, for example in the peer comparison further up this page.

In healthcare, relevant criteria include earnings stability, research intensity and margin quality, among others. StockScorer compares many metrics against the sector average, so a stock is positioned not only in absolute terms but also relative to its sector.

How StockScorer rates Evotec SE stock

StockScorer evaluates every stock entirely rule-based and without discretion. As a small-cap stock, Evotec SE carries particular emphasis on balance-sheet stability and earnings continuity. The criteria met across the 18 strategies produce the match shown per strategy as well as the summarising StockScorer score.

This makes it possible to see at a glance which investment styles a stock fits, without doing the calculation yourself. The decision remains yours. The values shown are purely informational and not investment advice.

Frequently asked questions about Evotec SE stock

How does Evotec SE stock (EVT.DE) score in the StockScorer model?

Evotec SE stock reaches a StockScorer score of 0.0 out of 10, which is a low match with the rule-based strategies. It fits the Growth category best. All values are purely rule-based and updated every business day.

What does the StockScorer score mean?

The StockScorer score summarises on a scale of 0 to 10 how many of the checked rule-based criteria a stock meets. A higher value means a higher match with the underlying strategies. The score is a neutral metric and not a recommendation to buy or sell.

What sector is Evotec SE in?

Evotec SE is assigned to the Healthcare sector. StockScorer uses the sector classification, among other things, to relate the stock to comparable peers from the same sector.

Is Evotec SE stock a buy?

StockScorer does not give buy, hold or sell recommendations. The page only shows how strongly the stock matches various rule-based strategies. Whether a stock fits your goals depends on your own assessment. This is not investment advice.

How up to date are the metrics?

Scores are recomputed every business day. Individual metrics such as P/E, ROE and margin, as well as the full peer comparison, are visible after a free sign-up, for licensing reasons.

Which stocks are comparable to Evotec SE?

In the same Healthcare sector, StockScorer rates Eli Lilly and Company, Eli Lilly and Company, Johnson & Johnson, among others. The full peer comparison with scores and match per strategy is available after signing up.

Which strategies does Evotec SE match?

Evotec SE shows a match with Mohanram G-Score: Wachstums-Qualität, Ertragsqualität: Accrual-Check (Sloan), PEG-Strategie nach Peter Lynch. The match across all strategies checked is visible after a free sign-up.

Keep exploring

Unlock the full analysis for free

Signed up in 30 seconds. Free, cancel anytime.

✓ All metrics: P/E, ROE, margin, debt, cash flow
✓ Full peer comparison within the same sector
✓ See the match across all strategies in detail
✓ Apply your own scoring profile to any stock
✓ Add the stock to your watchlist and track score changes
✓ Daily updated ratings for 500+ stocks

Start for free →Already registered? Log in now

Not investment advice. The match shown reflects rule-based criteria and is not a recommendation to buy, hold or sell. Individual metrics are only visible after signing in, for licensing reasons.

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.